** Hong Kong-listed shares of Shanghai Pharmaceuticals Holding Co Ltd fall as much as 7.4% to HK$16.40, their lowest since April 19
** Stock on course for the worst session since July 16, 2020
** Co's Shanghai-listed shares fall 6.9%
** Dual-listed Shanghai Pharmaceuticals plans sale of 14.4 bln yuan ($2.24 bln) A-shares to Shanghai Tandong Enterprise Consulting Services Co and Yunnan Baiyao Group Co
, raising proceeds to repay debt and for working capital
** Co plans sale of an aggregate 852.6 mln A shares at 16.87 yuan apiece, versus Tuesday's close of 21.74 yuan each
** The Hong Kong Hang Seng Commerce & Industry Index rises 1.3%
** The Hang Seng China enterprises index climbs 0.7%, and the benchmark index edges up 0.1%
** As of last close, the Hong Kong-listed stock up 29.7% this year